22nd Century Group, Inc. Files Definitive Proxy Statement

TL;DR

<b>22nd Century Group, Inc. has filed its definitive proxy statement, detailing operational shifts and strategic refocusing on its tobacco business.</b>

AI Summary

22nd Century Group, Inc. (XXII) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. 22nd Century Group, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 29, 2024. The filing covers the period ending June 28, 2024, with the as-of date of April 29, 2024. The company's principal executive offices are located at 8560 Main Street, Suite 4, Williamsville, NY 14221. The CEO, in office for 5 months, emphasizes candid communication and has heard shareholder feedback regarding unmet expectations and belief in the company's disruptive potential. Recent operational changes include the divestiture of the GVB hemp/cannabis business, consolidation of operations to North Carolina, and elimination of a second shift to improve productivity.

Why It Matters

For investors and stakeholders tracking 22nd Century Group, Inc., this filing contains several important signals. The filing signals a period of significant operational restructuring and strategic realignment for 22nd Century Group, Inc., including the divestiture of non-core assets and consolidation of facilities. Shareholder feedback, both positive and negative, is acknowledged, indicating a focus on addressing concerns and communicating transparently about the company's performance and future direction.

Risk Assessment

Risk Level: — 22nd Century Group, Inc. shows moderate risk based on this filing. The company has undergone significant operational changes, including divestitures and consolidations, which introduce inherent risks related to execution and integration, as evidenced by the closure of facilities and shift eliminations.

Analyst Insight

Investors should review the proxy statement for details on executive compensation, shareholder proposals, and the company's strategic direction following recent operational changes.

Key Numbers

• 5 — months (Duration the current CEO has been in office.)
• 100% — focus (Company's dedicated focus on its tobacco business.)

Key Players & Entities

• 22nd Century Group, Inc. (company) — Registrant and filer of the proxy statement.
• Williamsville, NY (location) — Location of the company's business and mailing address.
• GVB (company) — Divested hemp/cannabis business.
• North Carolina (location) — Location of the consolidated factory operations.

FAQ

Risk Factors

• Operational Restructuring [medium — operational]: The company has undergone significant operational changes, including divestiture of the GVB hemp/cannabis business and consolidation of facilities, which could impact future performance.

Industry Context

22nd Century Group operates within the tobacco industry, focusing on products designed to reduce harm from nicotine consumption.

Regulatory Implications

The filing is a standard DEF 14A, a proxy statement required by the SEC for public companies soliciting shareholder votes.

What Investors Should Do

1. Review the proxy statement for details on upcoming shareholder meetings and voting matters.
2. Analyze the company's strategic priorities and operational plans outlined in the CEO's letter and management discussion.
3. Assess executive compensation and any proposed changes to equity incentive plans.

Key Dates

• 2024-04-29T00:00:00.000Z: Filing Date — Definitive Proxy Statement (DEF 14A) filed.

Year-Over-Year Comparison

This filing is a DEF 14A, indicating a routine disclosure of proxy information, rather than a quarterly or annual report.

Filing Documents

• tm2412179-2_def14a.htm (DEF 14A) — 1113KB
• bc_capvstsr-4c.jpg (GRAPHIC) — 57KB
• ic_internet-pn.gif (GRAPHIC) — 2KB
• ic_mail-pn.gif (GRAPHIC) — 2KB
• ic_person-pn.gif (GRAPHIC) — 2KB
• ic_phone-pn.gif (GRAPHIC) — 2KB
• lg_22ndcenturygroupgrn-4clr.jpg (GRAPHIC) — 13KB
• px_2422ndcenturyannual01-bw.jpg (GRAPHIC) — 307KB
• px_2422ndcenturyannual02-bw.jpg (GRAPHIC) — 195KB
• sg_lawrencefirestone-bwlr.jpg (GRAPHIC) — 6KB
• 0001104659-24-054202.txt (&nbsp;) — 1892KB

From the Filing

DEF 14A 1 tm2412179-2_def14a.htm DEF 14A tm2412179-2_def14a - none - 12.2659837s TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 22nd Century Group, Inc. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. TABLE OF CONTENTS To the Shareholders of 22nd Century Group, Inc.: In the 5 months that I have been the CEO and Chairman of your company, I have gotten to know several of you on a first name basis and have received comments and feedback from many others. For those of you who don't yet know me, one thing you will come to find is that I am a believer in candid and straightforward communication. To the shareholders of this company, that means giving you the information you deserve to have in making your investment decisions, including our ups and downs, wins and losses. In short, I strive to communicate the business facts I would want to know in your shoes. Some of you have shared your perspectives with me on why you chose to become shareholders in the first place and why you still believe in the future of 22nd Century: our unique position in the industry, our disruptive potential, and our mission to reduce harm from nicotine consumption. Others have shared frustrations and disappointment at unmet expectations. For all your feedback, and speaking on behalf of the entire management team and the Board of Directors, let me say: We have heard you loud and clear. A Year of Transition So much has changed in the past 5 months at 22nd Century it's hard to know where to begin. Our divestiture of the GVB hemp/cannabis business was a great weight lifted from the company, both in terms of cost and attention drain. We closed our headquarters in Buffalo and our lab facilities in Maryland and consolidated all operations to our factory in North Carolina. We eliminated the second shift at the North Carolina facility and consolidated production to one shift for a substantial productivity gain. Most importantly, we have firmly returned our focus 100% to our tobacco business. We are fully dedicated to making 22nd Century a profitable, cash positive, NASDAQ listed company with a strong foothold in our industry sector, and once again centered in our mission of using our patented biotechnology for creation of products that address the harms of nicotine addiction and commercializing those products. In pursuing this mission, our priority is, "What is good for the future of company, comes first." As for the management team and Board of Directors, the changes are no less dramatic. All retention, severance, and other employment agreements have been eliminated. Bonus compensation and equity awards in the absence of profits are gone. Board compensation is suspended until after the 2024 Annual Shareholder Meeting. Spending on consultants and advisors has been terminated except only those few that are mission critical. Drive to Breakeven Throughout 2023, our hemp/cannabis segment was the largest source of cash burn as unfunded overhead drove some of our largest losses. Additionally, companies that have operations around cannabis have what I call a "cannabis tax" on the entire business. This tax comes in the form of a cost premium on just about every cost that the entire company incurs, such as insurance and financing. Therefore, selling the GVB business not only eliminated a substantial portion of our cash drain, but also allows us to lower costs in our core tobacco business going forward. In 2024 we are on a drive to financial breakeven for the first time in the company's history. The cost reductions mentioned above are part of closing that gap, as well as raising prices on unprofitable product lines. In addition, we are working on new profitable revenue opportunities for both VLN and the contract manufacturing or CMO business to drive higher gross profits to achieve our breakeven point as soon as possible. Renewed Focus on VLN Our flagship product VLN means Very Low Nicotine. We believe our trademarked brand, VLN , serves the same purpose for nicotine harm reduction from cigarettes as decaf coffee does for regular coffee. If anyone has told you that you need to cut back, our VLN offers a compelling alternative.

View Full Filing

View this DEF 14A filing on SEC EDGAR